MSLN and ovarian cancer: Specifically, MSLN has been shown to have oncogenic properties by increasing ovarian cancer invasion by inducing MMP-7 through MAPK/ERK and JNK pathways and by inducing drug resistance through PI3K/AKT and MAPK/ERK signaling pathways [65,74].